Title: North America Cell Line Development Market To Witness Lucrative Growth Through 2027
1 North America Cell Line Development Market to
expand lucratively till 2027
2018 Graphical Research. All rights
reserved.
www.graphicalresearch.com
2 - North America Cell Line Development Market To Hit
USD 2.9 Bn By 2027. North America cell line
development market forecast will be strong on the
back of developments in single-cell dispensaries,
micro-robotics and flow cytometry. Notably, flow
cytometry has gained uptick to boost efficiency
during research activities. Cell lines are
expected to be highly desirable in the growth of
viral vaccines, biologics production and
biopharmaceutical products. - Leading companies are expected to use cell lines
in the production of monoclonal antibodies and
recombinant proteins for cell culture and the
identification of single-cell clones. Moreover,
the prevalence of advanced technologies to
produce cell lines, coupled with the development
of regenerative medicine, will contribute to
market growth. - Expanding penetration of bioreactors has
stimulated growth potentials of cell line
development equipment. Several cell line
developments in drug screening and bioproduction
will encourage companies to invest in the
landscape. Besides, the use of robust storage
equipment and single-use bioreactors will be
pronounced over the next few years. North America
cell line development industry share from
equipment demand will grow at a healthy CAGR of
11 through 2027.
2018 Graphical Research. All rights
reserved.
www.graphicalresearch.com
3 - Get sample copy of this research report _at_
- https//www.graphicalresearch.com/request/1067/sam
ple - Request for customization _at_
- https//www.graphicalresearch.com/request/1067/cus
tomize-this-report
2018 Graphical Research. All rights
reserved.
www.graphicalresearch.com
4 - Mammalian cell line development could be dominant
with surging demand from biopharmaceutical
companies. It is worth noting that human
embryonic kidney cells and the Chinese hamster
ovary (CHO) are used in therapeutic protein
production. Mammalian source captured over 71
share of North America cell line development
market in 2020 and is expected to grow with the
demand for research and biologics production. - The trend for cell line development will be
apparent in drug discovery to assess the
efficiency of drug toxicity and minimize cost and
time during testing. Moreover, an upsurge in
demand for new cancer treatment will expedite the
need for cell line development. Drug discovery
applications contributed around 11.8 share of
North America cell line development industry in
2020. - Hybridoma cell lines could be one of the
fastest-growing segments due to wide application
in the production of immunoglobin and monoclonal
antibodies. It is worth noting that the
technology has become highly desirable in the
development of assay and research activities.
North America cell line development market share
from hybridoma segment is likely to grow at more
than 10 CAGR up to 2027. - U.S. market will provide compelling growth
opportunities on the heels of increasing
healthcare budget, drug discoveries and
technological advancements. Heightened awareness
about monoclonal antibodies, along with the
development of therapeutic drugs, will expedite
the adoption of cell line development. For
instance, demand for cell lines for vaccine
production has surged exponentially for the
treatment of smallpox and rotavirus. U.S. cell
line development industry revenue is expected to
observe around 11.4 CAGR through 2027.
2018 Graphical Research. All rights
reserved.
www.graphicalresearch.com
5 Segments of North American Cell Line
Development Market
- North America Market, By Product
- Reagents media
- Equipment
- Incubators
- Centrifuges
- Bioreactors
- Storage equipment
- Microscopes
- Accessories Consumables
- North America Market, By Source
- Mammalian
- Non-mammalian
- Insects
- Amphibians
2018 Graphical Research. All rights
reserved.
www.graphicalresearch.com
6 About Graphical Research Graphical Research is
a business research firm that provides industry
insights, market forecast and strategic inputs
through granular research reports and advisory
services. We publish targeted research reports
with an aim to address varied customer needs,
from market penetration and entry strategies to
portfolio management and strategic outlook. We
understand that business requirements are unique
our syndicate reports are designed to ensure
relevance for industry participants across the
value chain. We also provide custom reports that
are tailored to the exact needs of the customer,
with dedicated analyst support across the
purchase lifecycle. Contact Us Parikhit
B. Corporate sales, Graphical
Research Email sales_at_graphicalresearch.com Web
https//www.graphicalresearch.com
2018 Graphical Research. All rights
reserved.
www.graphicalresearch.com
7 Stay In Touch With Us For
Website www.graphicalresearch.com Socia
l Media
Assured Quality
On-Time Delivery
Industry Experts
Payment Security
2018 Graphical Research. All rights
reserved.
www.graphicalresearch.com